86 related articles for article (PubMed ID: 3723494)
1. Measures of immunologic and inflammatory responses in vitro in rheumatoid patients treated with methotrexate.
Johnston CA; Russell AS; Kovithavongs T; Dasgupta M
J Rheumatol; 1986 Apr; 13(2):294-6. PubMed ID: 3723494
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
3. Suppressive influences of methotrexate on the generation of CD14(+) monocyte-lineage cells from bone marrow of patients with rheumatoid arthritis.
Hirohata S; Yanagida T; Hashimoto H; Tomita T; Ochi T
Clin Immunol; 1999 Apr; 91(1):84-9. PubMed ID: 10219258
[TBL] [Abstract][Full Text] [Related]
4. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.
Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA
Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis.
Cutolo M; Bisso A; Sulli A; Felli L; Briata M; Pizzorni C; Villaggio B
J Rheumatol; 2000 Nov; 27(11):2551-7. PubMed ID: 11093433
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
[TBL] [Abstract][Full Text] [Related]
8. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
9. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
[TBL] [Abstract][Full Text] [Related]
10. The effective of methotrexate on immune response cells in rheumatoid arthritis.
Wiewiórowski M; Graczyk J
Acta Pol Pharm; 2000 Nov; 57 Suppl():138-9. PubMed ID: 11293246
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.
Genestier L; Paillot R; Fournel S; Ferraro C; Miossec P; Revillard JP
J Clin Invest; 1998 Jul; 102(2):322-8. PubMed ID: 9664073
[TBL] [Abstract][Full Text] [Related]
13. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.
Lacki JK; Schochat T; Sobieska M; Leszczynski P; Wiktorowicz K; Mackiewicz U; Mackiewicz SH; Müller W
Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte phenotype studies of rheumatoid arthritis patients treated with methotrexate.
Lacki JK; Mackiewicz SH; Wiktorowicz KE
Arch Immunol Ther Exp (Warsz); 1994; 42(4):287-90. PubMed ID: 7487368
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
17. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
18. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
[TBL] [Abstract][Full Text] [Related]
19. [Methotrexate in rheumatoid arthritis].
Alamo M; Grisanti M
Rev Med Chil; 1991 Jun; 119(6):691-700. PubMed ID: 1844376
[TBL] [Abstract][Full Text] [Related]
20. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS
J Rheumatol; 1984 Dec; 11(6):760-3. PubMed ID: 6394758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
